{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:08:49Z","timestamp":1792516129716,"version":"4.5.0"},"reference-count":272,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Br. J. Biomed. Sci."],"abstract":"<jats:p>Antimicrobial resistance (AMR) has caused a global public health crisis, contributing to approximately five million deaths in 2019 and predicted deaths of approximately ten million annually by 2050. This equates to approximately 1.4-fold more deaths annually from AMR in 2050 than the entire COVID-19 pandemic to date. To tackle this AMR pandemic, regulatory and policy frameworks have been prepared at local, national and international levels with multi-faceted proposals and advances encompassing surveillance, diagnostics, infection prevention, antibiotic prescribing and variation of existing and novel treatment approaches. This narrative review primarily focuses on research and development which have been documented over the last five\u00a0years in relation to therapeutic approaches at various stages in clinical development and the potential role that vaccines can play in the fight against AMR. This review provides an overview on antibacterial drugs, including novel classes of antibiotics, which have been recently approved, as well as combination antibiotic therapy and the potential of repurposed drugs. The potential role of novel antimicrobial, antibiofilm and quorum sensing inhibitors, such as antimicrobial peptides, nanomaterials and compounds from the extreme and natural environments, as well as ethnopharmacology including the antimicrobial effects of plants, spices, honey and venoms are explored. Novel therapeutic approaches are critically discussed in terms of their realistic clinical potential, detailing recent and ongoing trials to highlight the current interest of these approaches, including immunotherapy, bacteriophage therapy, antimicrobial photodynamic therapy (aPDT), antimicrobial sonodynamic therapy (aSDT), nitric oxide therapy and microbiome manipulation including faecal microbiota transplantation (FMT). The potential of predatory bacteria as living antimicrobial agents is also discussed. Importantly, there have been many technological developments which have enhanced bioprospecting and research and development of novel antimicrobials which this review draws attention to, including artificial intelligence, machine learning and Organ-on-a-Chip devices. Finally, key messages from the recent World Health Organization report into the role of vaccines against AMR provides an interesting perspective relating to prevention which can be of significance in tackling the AMR burden.<\/jats:p>","DOI":"10.3389\/bjbs.2026.15559","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:15:12Z","timestamp":1770390912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Antimicrobial Resistance: The Answers"],"prefix":"10.3389","volume":"83","author":[{"given":"Beverley C.","family":"Millar","sequence":"first","affiliation":[{"name":"Northern Ireland Public Health Laboratory, Belfast City Hospital","place":["Belfast, Northern Ireland, United Kingdom"]},{"name":"School of Biomedical Sciences, Ulster University","place":["Coleraine, Northern Ireland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Cates","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Ulster University","place":["Coleraine, Northern Ireland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco S.","family":"Torrisi","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Ulster University","place":["Coleraine, Northern Ireland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Round","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Ulster University","place":["Coleraine, Northern Ireland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Warde","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Ulster University","place":["Coleraine, Northern Ireland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm J.","family":"Lowery","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Ulster University","place":["Coleraine, Northern Ireland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Moore","sequence":"additional","affiliation":[{"name":"Northern Ireland Public Health Laboratory, Belfast City Hospital","place":["Belfast, Northern Ireland, United Kingdom"]},{"name":"School of Biomedical Sciences, Ulster University","place":["Coleraine, Northern Ireland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"B1","unstructured":"Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling Drug-Resistant Infections Globally: Final Report and Recommendations\n          \n          \n            \n              O\u2019Neill\n              J\n            \n          \n          \n          2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11387","DOI":"10.3389\/bjbs.2023.11387","article-title":"Antimicrobial Resistance (AMR)","volume":"80","author":"Tang","year":"2023","journal-title":"Br J Biomed Sci"},{"key":"B3","unstructured":"WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance\n          \n          \n          2024"},{"key":"B4","unstructured":"Monitoring and Evaluation of the Global Action Plan on Antimicrobial Resistance\n          \n          \n          2019"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/microorganisms11092277","article-title":"Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis","volume":"11","author":"Mancuso","year":"2023","journal-title":"Microorganisms"},{"key":"B6","unstructured":"WHO Announces Updated Definitions of Extensively Drug-Resistant Tuberculosis\n          \n          \n          2021"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1016\/S2666-5247(23)00370-1","article-title":"Antimicrobial-Resistant Neisseria gonorrhoeae in Europe in 2020 Compared with in 2013 and 2018: A Retrospective Genomic Surveillance Study","volume":"5","author":"Golparian","year":"2024","journal-title":"Lancet Microbe"},{"key":"B8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/antibiotics12020217","article-title":"Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future","volume":"12","author":"Perikleous","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3322\/caac.21697","article-title":"Antibiotic Resistance in the Patient with Cancer: Escalating Challenges and Paths Forward","volume":"71","author":"Nanayakkara","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1305294","DOI":"10.3389\/fphar.2023.1305294","article-title":"Antibiotic Action and Resistance: Updated Review of Mechanisms, Spread, Influencing Factors, and Alternative Approaches for Combating Resistance","volume":"14","author":"Halawa","year":"2024","journal-title":"Front Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/genes8010039","article-title":"The Complex Relationship Between Virulence and Antibiotic Resistance","volume":"8","author":"Schroeder","year":"2017","journal-title":"Genes (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.37349\/eds.2023.00013","article-title":"Approved Antibacterial Drugs in the Last 10 Years: From the Bench to the Clinic","volume":"1","author":"Garc\u00eda-Castro","year":"2023","journal-title":"Explor Drug Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3390\/molecules28041762","article-title":"A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects","volume":"28","author":"Shi","year":"2023","journal-title":"Molecules"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/antibiotics13111077","article-title":"Differences in Patient Access to Newly Approved Antibacterial Drugs in EU\/EEA Countries","volume":"13","author":"Zasheva","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cmi.2023.09.024","article-title":"Evaluating the Innovative Potential of the Global Antibacterial Pipeline","volume":"31","author":"Theuretzbacher","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"B16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/phar.2166","article-title":"Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic","volume":"38","author":"Veve","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B17","unstructured":"Tiamulin\n          \n          \n            \n              Poultry\n              DVM\n            \n          \n          \n          2025"},{"key":"B18","unstructured":"Xenlata\n          \n          \n          2020"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e89055","DOI":"10.1371\/journal.pone.0089055","article-title":"Reverse Zoonotic Disease Transmission (Zooanthroponosis): A Systematic Review of Seldom-Documented Human Biological Threats to Animals","volume":"9","author":"Messenger","year":"2014","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/jac\/dkad060","article-title":"Gepotidacin: A Novel, Oral, 'First-In-Class' Triazaacenaphthylene Antibiotic for the Treatment of Uncomplicated Urinary Tract Infections and Urogenital Gonorrhoea","volume":"78","author":"Watkins","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","article-title":"Oral Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhoea (EAGLE-1): A Phase 3 Randomised, Open-Label, Non-Inferiority, Multicentre Study","volume":"405","author":"Ross","year":"2025","journal-title":"Lancet"},{"key":"B22","article-title":"Public Law 112\u2013144 112th Congress","year":"2012","journal-title":"Food Drug Adm Saf Innovation Act"},{"key":"B23","unstructured":"Food and Drug Administration Safety and Innovation Act (FDASIA)\n          \n          \n          2018"},{"key":"B24","unstructured":"Qualified Infectious Disease Product Designation-Questions and Answers Guidance for Industry\n          \n          \n          2021"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s40265-021-01576-0","article-title":"Contezolid: First Approval","volume":"81","author":"Hoy","year":"2021","journal-title":"Drugs"},{"key":"B26","unstructured":"Micurx Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid Acefosamil\n          \n          \n          2023"},{"key":"B27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/IDR.S499816","article-title":"Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a Prospective and Randomized Early Bactericidal Activity Study","volume":"18","author":"Jiang","year":"2025","journal-title":"Infect Drug Resist"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1186\/s12879-024-10157-x","article-title":"The Antibiotic Therapy Containing Contezolid Successfully Treated methicillin-Sensitive Staphylococcus aureus Infective Endocarditis Accompanied with Cerebrovascular Complications","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/IDR.S502839","article-title":"Sequential Therapy of Linezolid and Contezolid to Treat Hematogenous Lung Abscess Caused by Staphylococcus aureus in a Congenital Cerebral Hypoplasia Patient: A Case Report","volume":"18","author":"Zhou","year":"2025","journal-title":"Infect Drug Resist"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0088921","DOI":"10.1128\/AAC.00889-21","article-title":"A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium Abscessus Activity in Vitro","volume":"65","author":"Guo","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2147\/IDR.S401533","article-title":"Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report","volume":"16","author":"Chen","year":"2023","journal-title":"Infect Drug Resist"},{"key":"B32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2147\/IDR.S501604","article-title":"Efficacy of Contezolid in the Treatment of Catheter-Related Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus in a Patient with Hepatorenal Syndrome and Acute Kidney Injury: A Case Report","volume":"18","author":"Zhang","year":"2025","journal-title":"Infect Drug Resist"},{"key":"B33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/pathogens14030218","article-title":"Comparative in Vitro Drug Susceptibility Study of Five Oxazolidinones Against Mycobacterium tuberculosis in Hainan, China","volume":"14","author":"Dong","year":"2025","journal-title":"Pathogens"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1093\/jac\/dkae331","article-title":"Multicentre Evaluation of In Vitro Activity of Contezolid Against Drug-Resistant Staphylococcus and Enterococcus","volume":"79","author":"Yang","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2147\/IDR.S453541","article-title":"Contezolid-Containing Regimen Successfully Treated Multiple Drug Resistance Mycobacterium abscessus Complex Infection of Skin: A Case Report and Literature Review","volume":"17","author":"Gao","year":"2024","journal-title":"Infect Drug Resist"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0462722","DOI":"10.1128\/spectrum.04627-22","article-title":"In vitro Activities of Contezolid (MRX-I) Against Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis","volume":"11","author":"An","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0182824","DOI":"10.1128\/aac.01828-24","article-title":"Triple Antimicrobial Combinations with Potent Synergistic Activity Against M. abscessus","volume":"69","author":"Huang","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s11739-021-02749-1","article-title":"Advances in Novel Antibiotics to Treat Multidrug-Resistant Gram-Negative Bacterial Infections","volume":"16","author":"Matlock","year":"2021","journal-title":"Intern Emerg Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/pathogens14040307","article-title":"New \u03b2-Lactam\/\u03b2-Lactamase Inhibitor Combination Antibiotics","volume":"14","author":"Sargianou","year":"2025","journal-title":"Pathogens"},{"key":"B40","unstructured":"EMBLAVEO\u00ae (aztreonam\/Avibactam)\n          \n          \n          2025"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s40265-023-01920-6","article-title":"Sulbactam\/Durlobactam: First Approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"B42","unstructured":"Combined Antibiotic Approved to Treat Adult Patients with Severe Infections of the Urinary Tract and Hospital-Acquired Pneumonia\n          \n          \n          2024"},{"key":"B43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/17460913.2025.2468112","article-title":"Cefepime-Enmetazobactam: First Approved Cefepime-\u03b2- Lactamase Inhibitor Combination for Multi-Drug Resistant Enterobacterales","volume":"20","author":"Bhowmick","year":"2025","journal-title":"Future Microbiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/ajhp\/zxab012","article-title":"Imipenem\/Cilastatin\/Relebactam: A New Carbapenem \u03b2-Lactamase Inhibitor Combination","volume":"78","author":"Mansour","year":"2021","journal-title":"Am J Health Syst Pharm"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/antibiotics12111612","article-title":"Meropenem\/Vaborbactam: \u0392-Lactam\/\u0392-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance","volume":"12","author":"Duda-Madej","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/fmb-2023-0197","article-title":"Perspectives on the Use of ceftolozane\/tazobactam: A Review of Clinical Trial Data and Real-World Evidence","volume":"19","author":"Martin-Loeches","year":"2024","journal-title":"Future Microbiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cmi.2020.03.007","article-title":"Evaluation of Polymyxin B in Combination with 13 Other Antibiotics Against Carbapenemase-Producing Klebsiella pneumoniae in Time-Lapse Microscopy and Time-Kill Experiments","volume":"26","author":"Wistrand-Yuen","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B48","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.tpr.2024.100170","article-title":"Multi-Target Combination of Antibiotics as Salvage Therapy for Severe Infection Caused by Pan-Resistant Burkholderia cenocepacia Following Lung Transplantation","volume":"10","author":"Cassir","year":"2025","journal-title":"Transplant Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"116833","DOI":"10.1016\/j.ejmech.2024.116833","article-title":"Drug Repurposing Against Antibiotic Resistant Bacterial Pathogens","volume":"279","author":"Aggarwal","year":"2024","journal-title":"Eur J Med Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1130","DOI":"10.52225\/narra.v5i1.1130","article-title":"Computational Drug Repurposing for Tuberculosis by Inhibiting Ag85 Complex Proteins","volume":"5","author":"Iskandar","year":"2025","journal-title":"Narra J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/antibiotics14040402","article-title":"Repurposing High-Throughput Screening Reveals Unconventional Drugs with Antimicrobial and Antibiofilm Potential Against Methicillin-Resistant Staphylococcus aureus from a Cystic Fibrosis Patient","volume":"14","author":"Pompilio","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0238195","DOI":"10.1371\/journal.pone.0238195","article-title":"Propranolol, Chlorpromazine and Diclofenac Restore Susceptibility of Extensively Drug-Resistant (XDR)-Acinetobacter Baumannii to Fluoroquinolones","volume":"15","author":"Mohammed","year":"2020","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12088-024-01280-z","article-title":"Antimicrobial Proficiency of Amlodipine: Investigating Its Impact on Pseudomonas spp. in Urinary Tract Infections","volume":"65","author":"Sharma","year":"2025","journal-title":"Indian J Microbiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/biom14121497","article-title":"Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis","volume":"14","author":"Raqib","year":"2024","journal-title":"Biomolecules"},{"key":"B55","doi-asserted-by":"publisher","first-page":"106281","DOI":"10.1016\/j.micpath.2023.106281","article-title":"Anti-Virulence Prospects of Metformin Against Pseudomonas Aeruginosa: A New Dimension to a Multifaceted Drug","volume":"183","author":"Chadha","year":"2023","journal-title":"Microb Pathog"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0071925","DOI":"10.1128\/spectrum.00719-25","article-title":"VLX600, an Anticancer Iron Chelator, Exerts Antimicrobial Effects on Mycobacterium abscessus Infections","volume":"20","author":"Oh","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B57","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3934\/microbiol.2025007","article-title":"Repurposing of Paroxetine and Fluoxetine for Their Antibacterial Effects Against Clinical Pseudomonas aeruginosa Isolates in Egypt","volume":"11","author":"Baraka","year":"2025","journal-title":"AIMS Microbiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.3390\/ijms23095029","article-title":"Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin Against Cystic Fibrosis Pseudomonas aeruginosa Strains","volume":"23","author":"Di Bonaventura","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"106468","DOI":"10.1016\/j.micpath.2023.106468","article-title":"Repurposing Albendazole as a Potent Inhibitor of Quorum Sensing-Regulated Virulence Factors in Pseudomonas Aeruginosa: Novel Prospects of a Classical Drug","volume":"186","author":"Chadha","year":"2024","journal-title":"Microb Pathog"},{"key":"B60","doi-asserted-by":"publisher","first-page":"ovaf086","DOI":"10.1093\/lambio\/ovaf086","article-title":"Bactericidal and Anti-Biofilm Activity of Ebastine Against Staphylococcus aureus","volume":"12","author":"Zhao","year":"2025","journal-title":"Lett Appl Microbiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s13205-024-04070-y","article-title":"Revitalizing Common Drugs for Antibacterial, Quorum Quenching, and Antivirulence Potential Against Pseudomonas aeruginosa: In Vitro and in Silico Insights","volume":"14","author":"Chadha","year":"2024","journal-title":"3 Biotech"},{"key":"B62","doi-asserted-by":"publisher","first-page":"107369","DOI":"10.1016\/j.micpath.2025.107369","article-title":"Repurposing Astemizole to Kill Multidrug-Resistant Bacteria Isolated in General Surgery","volume":"200","author":"Cao","year":"2025","journal-title":"Microb Pathog"},{"key":"B63","doi-asserted-by":"publisher","first-page":"16114","DOI":"10.1038\/s41598-025-01303-9","article-title":"Penfluridol Synergizes with Colistin to Reverse Colistin Resistance in Gram-Negative Bacilli","volume":"15","author":"Chatupheeraphat","year":"2025","journal-title":"Sci Rep"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e2423650122","DOI":"10.1073\/pnas.2423650122","article-title":"Repurposing a Drug to Punish Carbapenem-Resistant Acinetobacter Baumannii","volume":"122","author":"Colquhoun","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B65","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12866-025-03973-x","article-title":"Fingolimod as a Potent Anti-Staphylococcus Aureus: Ph-Dependent Cell Envelope Damage and Eradication of biofilms\/persisters","volume":"25","author":"Shang","year":"2025","journal-title":"BMC Microbiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"177480","DOI":"10.1016\/j.ejphar.2025.177480","article-title":"Aspirin Enhances the Antibacterial Activity of Colistin Against Multidrug-Resistant Pseudomonas aeruginosa","volume":"997","author":"Zhang","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejmech.2019.01.046","article-title":"Repurposing Ibuprofen to Control Staphylococcus aureus Biofilms","volume":"166","author":"Oliveira","year":"2019","journal-title":"Eur J Med Chem"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e1012705","DOI":"10.1371\/journal.ppat.1012705","article-title":"Diclofenac Sensitizes Multi-Drug Resistant Acinetobacter baumannii to Colistin","volume":"20","author":"Bisaro","year":"2024","journal-title":"Plos Pathog"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00284-021-02386-z","article-title":"Identification of Eltrombopag as a Repurposing Drug Against Staphylococcus epidermidis and Its Biofilms","volume":"78","author":"Zhu","year":"2021","journal-title":"Curr Microbiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"790686","DOI":"10.3389\/fmicb.2021.790686","article-title":"Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus","volume":"12","author":"She","year":"2022","journal-title":"Front Microbiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1093\/jac\/dkac319","article-title":"Niclosamide as a Repurposing Drug Against Gram-Positive Bacterial Infections","volume":"77","author":"Zhang","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.3390\/molecules27092995","article-title":"The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance","volume":"27","author":"Lopes","year":"2022","journal-title":"Molecules"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1119574","DOI":"10.3389\/fimmu.2023.1119574","article-title":"Antimicrobial Peptides\u00b4 Immune Modulation Role in Intracellular Bacterial Infection","volume":"14","author":"Duarte-Mata","year":"2023","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"7373","DOI":"10.1021\/acs.jcim.5c00530","article-title":"Deep Learning in Antimicrobial Peptide Prediction","volume":"8","author":"Lin","year":"2025","journal-title":"J Chem Inf Model"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1021\/acs.accounts.0c00594","article-title":"AI-Driven Antimicrobial Peptide Discovery: Mining and Generation","volume":"58","author":"Szymczak","year":"2025","journal-title":"Acc Chem Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/antibiotics9010024","article-title":"Development and Challenges of Antimicrobial Peptides for Therapeutic Applications","volume":"9","author":"Chen","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"B77","unstructured":"Roche Takes New Antibiotic into Phase 3 for 'Urgent Threat\n          \n          \n            \n              Taylor\n              P\n            \n          \n          \n          2025"},{"key":"B78","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-023-06873-0","article-title":"A Novel Antibiotic Class Targeting the Lipopolysaccharide Transporter","volume":"625","author":"Zampaloni","year":"2024","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s44259-024-00046-3","article-title":"Mechanisms of Antimicrobial Resistance in Biofilms. NPJ Antimicrob Resist","volume":"2","author":"Liu","year":"2024","journal-title":"NPJ Antimicrob Resist"},{"key":"B80","doi-asserted-by":"publisher","first-page":"107323","DOI":"10.1016\/j.ijantimicag.2024.107323","article-title":"Strategies for Quorum Sensing Inhibition as a Tool for Controlling Pseudomonas aeruginosa Infections","volume":"64","author":"Rodr\u00edguez-Urretavizcaya","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/jcp.30683","article-title":"Therapeutic Strategies Against Potential Antibiofilm Targets of Multidrug-Resistant Acinetobacter baumannii","volume":"237","author":"Kaushik","year":"2022","journal-title":"J Cell Physiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tim.2018.12.010","article-title":"Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance","volume":"27","author":"Ghosh","year":"2019","journal-title":"Trends Microbiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e01938","DOI":"10.1128\/AAC.01938-16","article-title":"Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers","volume":"61","author":"Howard","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/jac\/dky058","article-title":"Morpholino Oligomers Tested In Vitro, in Biofilm and In Vivo Against Multidrug-Resistant Klebsiella pneumoniae","volume":"73","author":"Geller","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/AAC.01542-08","article-title":"Novel Anion Liposome-Encapsulated Antisense Oligonucleotide Restores Susceptibility of Methicillin-Resistant Staphylococcus aureus and Rescues Mice from Lethal Sepsis by Targeting mecA","volume":"53","author":"Meng","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B86","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/jac\/dkw476","article-title":"Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer (PPMO) Restores Carbapenem Susceptibility to NDM-1-Positive Pathogens In Vitro and In Vivo","volume":"72","author":"Sully","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1021\/acsinfecdis.9b00123","article-title":"AcrAB-TolC Inhibition by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity in Vitro and in Vivo","volume":"5","author":"Sturge","year":"2019","journal-title":"ACS Infect Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e02411","DOI":"10.1128\/mBio.02411-20","article-title":"Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity Against Multidrug-Resistant Pseudomonas aeruginosa in Vitro and in Vivo. mBio","volume":"12","author":"Moustafa","year":"2021"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0024523","DOI":"10.1128\/aac.00245-23","article-title":"Sequence Specificity Defines the Effectiveness of PPMOs Targeting Pseudomonas aeruginosa","volume":"67","author":"Nanayakkara","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","article-title":"The Antimicrobial Activity of Nanoparticles: Present Situation and Prospects for the Future","volume":"12","author":"Wang","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B91","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tifs.2020.03.008","article-title":"Active Delivery of Antimicrobial Nanoparticles into Microbial Cells Through Surface Functionalization Strategies","volume":"99","author":"Bahrami","year":"2020","journal-title":"Trends Food Sci and Technology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"100473","DOI":"10.1016\/j.apmt.2019.100473","article-title":"Engineered Nanomaterials for Antimicrobial Applications: A Review","volume":"18","author":"Ogunsona","year":"2020","journal-title":"Appl Mater Today"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.drudis.2016.04.009","article-title":"Metal-Organic Frameworks: Mechanisms of Antibacterial Action and Potential Applications","volume":"21","author":"Wyszogrodzka","year":"2016","journal-title":"Drug Discov Today"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1021\/acsanm.1c03891","article-title":"Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review","volume":"5","author":"Ribeiro","year":"2022","journal-title":"ACS Appl Nano Mater"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.4c03668","article-title":"The Synergy Between Antibiotics and the Nanoparticle-Based Photodynamic Effect","author":"Marfavi","year":"2024","journal-title":"Nano Lett"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e0181363","DOI":"10.1371\/journal.pone.0181363","article-title":"Obliteration of Bacterial Growth and Biofilm Through ROS Generation by Facilely Synthesized Green Silver Nanoparticles","volume":"12","author":"Qayyum","year":"2017","journal-title":"PLoS One"},{"key":"B97","doi-asserted-by":"publisher","first-page":"662","DOI":"10.5312\/wjo.v14.i9.662","article-title":"Silver Nanoparticle Technology in Orthopaedic Infections","volume":"14","author":"Jeyaraman","year":"2023","journal-title":"World J Orthop"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1039\/c9nr08234d","article-title":"Wound Dressings Functionalized with Silver Nanoparticles: Promises and Pitfalls","volume":"12","author":"Kalantari","year":"2020","journal-title":"Nanoscale"},{"key":"B99","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/hygiene3030020","article-title":"Antimicrobial Nanomaterials: A Review","volume":"3","author":"Y\u0131lmaz","year":"2023","journal-title":"Hygiene"},{"key":"B100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/antibiotics13010029","article-title":"Searching for Antimicrobial-Producing Bacteria from Soils Through an Educational Project and Their Evaluation as Potential Biocontrol Agents","volume":"13","author":"Pino-Hurtado","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1038\/nprot.2017.074","article-title":"In situ Cultivation of Previously Uncultivable Microorganisms Using the Ichip","volume":"12","author":"Berdy","year":"2017","journal-title":"Nat Protoc"},{"key":"B102","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A New Antibiotic Kills Pathogens Without Detectable Resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41586-022-05019-y","article-title":"Teixobactin Kills Bacteria by a Two-Pronged Attack on the Cell Envelope","volume":"608","author":"Shukla","year":"2022","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-5058118\/v1","article-title":"A Broad Spectrum Lasso Peptide Antibiotic Targeting the Bacterial Ribosome","author":"Wright","year":"2024","journal-title":"Res Sq"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41586-025-08723-7","article-title":"A Broad-Spectrum Lasso Peptide Antibiotic Targeting the Bacterial Ribosome","volume":"640","author":"Jangra","year":"2025","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","first-page":"48","DOI":"10.9734\/ajrb\/2025\/v15i1350","article-title":"Therapeutic Potentials of Phytochemicals in Combatting Antimicrobial Resistance (AMR)","volume":"15","author":"Popoola","year":"2025","journal-title":"Asian J Res Biochem"},{"key":"B107","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/metabo9110258","article-title":"A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery","volume":"9","author":"Anand","year":"2019","journal-title":"Metabolites"},{"key":"B108","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/lam.13534","article-title":"Fighting Antimicrobial Resistance (AMR): Chinese Herbal Medicine as a Source of Novel Antimicrobials - An Update","volume":"73","author":"Millar","year":"2021","journal-title":"Lett Appl Microbiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.jpha.2024.101117","article-title":"Advances and Mechanisms of Traditional Chinese Medicine and Its Active Ingredients Against Antibiotic-Resistant Escherichia coli Infections","volume":"15","author":"Yang","year":"2025","journal-title":"J Pharm Anal"},{"key":"B110","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bioorg.2017.05.011","article-title":"Comparison of Seven Structurally Related Coumarins on the Inhibition of Quorum Sensing of Pseudomonas aeruginosa and Chromobacterium violaceum","volume":"73","author":"D'Almeida","year":"2017","journal-title":"Bioorg Chem"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.phymed.2016.11.001","article-title":"Synergism of Coumarins from the Chinese Drug Zanthoxylum nitidum with Antibacterial Agents Against Methicillin-Resistant Staphylococcus aureus (MRSA)","volume":"23","author":"Zuo","year":"2016","journal-title":"Phytomedicine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/gels11030194","article-title":"A Comprehensive Review of Honey-Containing Hydrogel for Wound Healing Applications","volume":"11","author":"Zainuddin","year":"2025","journal-title":"Gels"},{"key":"B113","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/antibiotics14030255","article-title":"Honey as a Natural Antimicrobial","volume":"14","author":"Ogwu","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/antibiotics14020172","article-title":"Antimicrobial Properties of Hive Products and Their Potential Applications in Human and Veterinary Medicine","volume":"14","author":"Bava","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"B115","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/antibiotics14020146","article-title":"Synergistic Antibiofilm Effects of Chestnut and Linden Honey with Lavender Essential Oil Against Multidrug-Resistant Otitis Media Pathogens","volume":"14","author":"\u00c1ngy\u00e1n","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e0224495","DOI":"10.1371\/journal.pone.0224495","article-title":"Antibacterial Activity of Varying UMF-Graded Manuka Honeys","volume":"14","author":"Girma","year":"2019","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1003933","article-title":"Antimicrobial Properties of Natural Honey","volume-title":"Melittology - New Advances","author":"Abdellah","year":"2023"},{"key":"B118","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/antibiotics10050551","article-title":"Honey as an Ecological Reservoir of Antibacterial Compounds Produced by Antagonistic Microbial Interactions in Plant Nectars, Honey and Honey Bee","volume":"10","author":"Brudzynski","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"B119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/antibiotics8040251","article-title":"Dissecting the Antimicrobial Composition of Honey","volume":"8","author":"Nolan","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1099522","DOI":"10.3389\/fmicb.2022.1099522","article-title":"Microbiome Analysis of Raw Honey Reveals Important Factors Influencing the Bacterial and Fungal Communities","volume":"13","author":"Xiong","year":"2023","journal-title":"Front Microbiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/antibiotics14010003","article-title":"Effectiveness of a Novel Liposomal Methylglyoxal-Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion","volume":"14","author":"Alluhaim","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B122","doi-asserted-by":"publisher","first-page":"629","DOI":"10.14719\/pst.2021.8.3.1152","article-title":"A Review: Antimicrobial Activity of the Medicinal Spice Plants to Cure Human Disease","volume":"8","author":"Mayekar","year":"2021","journal-title":"Plant Sci Today"},{"key":"B123","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/ijmy.ijmy_72_18","article-title":"Interaction of South Asian Spices with Conventional Antibiotics: Implications for Antimicrobial Resistance for Mycobacterium abscessus and Cystic Fibrosis","volume":"7","author":"Moore","year":"2018","journal-title":"Int J Mycobacteriol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e0236505","DOI":"10.1371\/journal.pone.0236505","article-title":"Synergistic Effects of Cinnamomum Cassia L. Essential Oil in Combination with Polymyxin B Against Carbapenemase-Producing Klebsiella pneumoniae and Serratia marcescens","volume":"15","author":"Vasconcelos","year":"2020","journal-title":"PLoS One"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e0314958","DOI":"10.1371\/journal.pone.0314958","article-title":"Potential of Methanol Extracts of Nephelium lappaceum (Sapindaceae) and Hyphaene thebaica (Arecaceae) as Adjuvants to Enhance the Efficacy of Antibiotics Against Critical Class Priority Bacteria","volume":"20","author":"Seukep","year":"2025","journal-title":"PLoS One"},{"key":"B126","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/antibiotics12020325","article-title":"Antimicrobial Activity of Spices Popularly Used in Mexico Against Urinary Tract Infections","volume":"12","author":"Ortega-Lozano","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B127","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3390\/ijms26083875","article-title":"Mediterranean Plants and Spices as a Source of Bioactive Essential Oils for Food Applications: Chemical Characterisation and in Vitro Activity","volume":"26","author":"Barbieri","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11274-024-04248-9","article-title":"Evaluating the Antibacterial Efficacy of Bee Venom Against Multidrug-Resistant Pathogenic Bacteria: Escherichia coli, Salmonella typhimurium, and Enterococcus faecalis","volume":"41","author":"El-Bilawy","year":"2025","journal-title":"World J Microbiol Biotechnol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/biology14010021","article-title":"Antibacterial Potential of Honeybee Venom and Monascus purpureus Extracellular Metabolites Against Multidrug-Resistant Pathogenic Bacteria","volume":"14","author":"Teiba","year":"2024","journal-title":"Biology (Basel)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/toxins16110466","article-title":"Peptide Toxin Diversity and a Novel Antimicrobial Peptide from the Spider Oxyopes forcipiformis","volume":"16","author":"Wang","year":"2024","journal-title":"Toxins (Basel)"},{"key":"B131","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/md22080333","article-title":"Jellyfish Venom Peptides Targeting Human Potassium Channels Identified Through Ligand Screening: Morphometric and Molecular Identification of the Species and Antibiotic Potential","volume":"22","author":"Edirisinghe","year":"2024","journal-title":"Mar Drugs"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/antibiotics12091380","article-title":"Scorpion Venom as a Source of Antimicrobial Peptides: Overview of Biomolecule Separation, Analysis and Characterization Methods","volume":"12","author":"Nasr","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e00267","DOI":"10.1128\/mSphere.00267-21","article-title":"Scorpion Venom Antimicrobial Peptides Induce Siderophore Biosynthesis and Oxidative Stress Responses in Escherichia coli","volume":"6","author":"Tawfik","year":"2021","journal-title":"mSphere"},{"key":"B134","doi-asserted-by":"publisher","first-page":"819921","DOI":"10.3389\/fvets.2022.819921","article-title":"The Antimicrobial Peptide MPX Can Kill Staphylococcus aureus, Reduce Biofilm Formation, and Effectively Treat Bacterial Skin Infections in Mice","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Vet Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.toxicon.2017.02.020","article-title":"Insects, Arachnids and Centipedes Venom: A Powerful Weapon Against Bacteria. A Literature Review","volume":"130","author":"Fratini","year":"2017","journal-title":"Toxicon"},{"key":"B136","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/toxins12090606","article-title":"Antibiofilm Activity of Acidic Phospholipase Isoform Isolated from Bothrops erythromelas Snake Venom","volume":"12","author":"Nunes","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e00810","DOI":"10.1016\/j.btre.2023.e00810","article-title":"Inhibition of Bacterial Biofilms by the Snake Venom Proteome","volume":"39","author":"Khan","year":"2023","journal-title":"Biotechnol Rep (Amst)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/toxins10020051","article-title":"Antimycobacterial Activity: A New Pharmacological Target for Conotoxins Found in the First Reported Conotoxin from Conasprella ximenes","volume":"10","author":"Figueroa-Montiel","year":"2018","journal-title":"Toxins (Basel)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s44259-024-00025-8","article-title":"Going to Extremes: Progress in Exploring New Environments for Novel Antibiotics","volume":"2","author":"Quinn","year":"2024","journal-title":"NPJ Antimicrob Resist"},{"key":"B140","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1029\/2018GL078133","article-title":"Ultralow Surface Temperatures in East Antarctica from Satellite Thermal Infrared Mapping: The Coldest Places on Earth","volume":"45","author":"Scambos","year":"2018","journal-title":"Geophys Res Lett"},{"key":"B141","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/antibiotics7040090","article-title":"Advances in Antarctic Research for Antimicrobial Discovery: A Comprehensive Narrative Review of Bacteria from Antarctic Environments as Potential Sources of Novel Antibiotic Compounds Against Human Pathogens and Microorganisms of Industrial Importance","volume":"7","author":"N\u00fa\u00f1ez-Montero","year":"2018","journal-title":"Antibiotics (Basel)"},{"key":"B142","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00203-023-03691-w","article-title":"Genome Mining Reveals Secondary Metabolites of Antarctic Bacterium Streptomyces albidoflavus Related to Antimicrobial and Antiproliferative Activities","volume":"205","author":"de Fran\u00e7a","year":"2023","journal-title":"Arch Microbiol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e202218085","DOI":"10.1002\/anie.202218085","article-title":"Somalactams A-D: Anti-Inflammatory Macrolide Lactams with Unique Ring Systems from an Arctic Actinomycete Strain","volume":"62","author":"Yang","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e20210840","DOI":"10.1590\/0001-3765202220210840","article-title":"Antarctic Organisms as a Source of Antimicrobial Compounds: A Patent Review","volume":"94","author":"Silva","year":"2022","journal-title":"An Acad Bras Cienc"},{"key":"B145","doi-asserted-by":"publisher","first-page":"171311","DOI":"10.1016\/j.peptides.2024.171311","article-title":"Membrane Alteration, Anti-Virulence Properties and Metabolomic Perturbation of a Chionodracine-Derived Antimicrobial Peptide, KHS-Cnd, on Two Bacteria Models","volume":"82","author":"Imperlini","year":"2024","journal-title":"Peptides"},{"key":"B146","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/antibiotics9020066","article-title":"Trematocine, a Novel Antimicrobial Peptide from the Antarctic Fish Trematomus Bernacchii: Identification and Biological Activity","volume":"9","author":"Della","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1447301","DOI":"10.3389\/fmicb.2024.1447301","article-title":"Trematocine-Derived Antimicrobial Peptides from the Antarctic Fish Trematomus bernacchaii: Potent Antibacterial Agents Against ESKAPE Pathogens","volume":"15","author":"Squitieri","year":"2024","journal-title":"Front Microbiol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/jfd.13797","article-title":"Identification of Antibacterial Activity of LEAP2 from Antarctic Icefish Chionodraco Hamatus","volume":"46","author":"Fei","year":"2023","journal-title":"J Fish Dis"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e0170821","DOI":"10.1371\/journal.pone.0170821","article-title":"Characterization of Two Antimicrobial Peptides from Antarctic Fishes (Notothenia coriiceps and Parachaenichthys charcoti)","volume":"12","author":"Shin","year":"2017","journal-title":"PLoS One"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1085063","DOI":"10.3389\/fmicb.2022.1085063","article-title":"A Symbiotic Bacterium of Antarctic Fish Reveals Environmental Adaptability Mechanisms and Biosynthetic Potential Towards Antibacterial and Cytotoxic Activities","volume":"13","author":"Xiao","year":"2023","journal-title":"Front Microbiol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/microorganisms12061228","article-title":"A Genomics-Based Discovery of Secondary Metabolite Biosynthetic Gene Clusters in the Potential Novel Strain Streptomyces sp. 21So2-11 Isolated from Antarctic Soil","volume":"12","author":"Du","year":"2024","journal-title":"Microorganisms"},{"key":"B152","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/md22020061","article-title":"Cold-Azurin, a New Antibiofilm Protein Produced by the Antarctic Marine Bacterium Pseudomonas sp. TAE6080","volume":"22","author":"D'Angelo","year":"2024","journal-title":"Mar Drugs"},{"key":"B153","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00792-024-01339-1","article-title":"Antarctic Marine Sediment as a Source of Filamentous Fungi-Derived Antimicrobial and Antitumor Compounds of Pharmaceutical Interest","volume":"28","author":"Camacho","year":"2024","journal-title":"Extremophiles"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/antibiotics12101556","article-title":"Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens","volume":"12","author":"Artini","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B155","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/md20120747","article-title":"CATASAN Is a New Anti-Biofilm Agent Produced by the Marine Antarctic Bacterium Psychrobacter sp. TAE2020","volume":"20","author":"D'Angelo","year":"2022","journal-title":"Mar Drugs"},{"key":"B156","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1134\/S0012496622060151","article-title":"Enzymatic and Antimicrobial Activities in Polar Strains of Microscopic Soil Fungi","volume":"507","author":"Nikitin","year":"2022","journal-title":"Dokl Biol Sci"},{"key":"B157","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12866-023-02770-8","article-title":"Bioprospecting of Desert Actinobacteria with Special Emphases on Griseoviridin, Mitomycin C and a New Bacterial Metabolite Producing Streptomyces sp. PU-KB10-4","volume":"23","author":"Saleem","year":"2023","journal-title":"BMC Microbiol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/lam.12412","article-title":"A Novel Hydroxamic Acid-Containing Antibiotic Produced by a Saharan Soil-Living Streptomyces Strain","volume":"60","author":"Yekkour","year":"2015","journal-title":"Lett Appl Microbiol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/ja.2015.70","article-title":"Xiakemycin A, a Novel Pyranonaphthoquinone Antibiotic, Produced by the Streptomyces sp. CC8-201 from the Soil of a Karst Cave","volume":"68","author":"Jiang","year":"2015","journal-title":"J Antibiot (Tokyo)"},{"key":"B160","doi-asserted-by":"publisher","first-page":"103111","DOI":"10.1016\/j.eti.2023.103111","article-title":"Harnessing Volcanic Silica Nanoparticles for Antibacterial Applications","volume":"30","author":"Saeed","year":"2023","journal-title":"Environ Technology and Innovation"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00203-020-01851-w","article-title":"Marine Bacteria Associated with Shallow Hydrothermal Systems in the Gulf of California with the Capacity to Produce Biofilm Inhibiting Compounds","volume":"202","author":"Guti\u00e9rrez-Almada","year":"2020","journal-title":"Arch Microbiol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"fiab103","DOI":"10.1093\/femsec\/fiab103","article-title":"Deep-Sea Hydrothermal Vent Sediments Reveal Diverse Fungi with Antibacterial Activities","volume":"97","author":"Keeler","year":"2021","journal-title":"FEMS Microbiol Ecol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/md19030176","article-title":"A Crustin from Hydrothermal Vent Shrimp: Antimicrobial Activity and Mechanism","volume":"19","author":"Wang","year":"2021","journal-title":"Mar Drugs"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1477458","DOI":"10.3389\/fmicb.2024.1477458","article-title":"Secondary Metabolites with Antimicrobial Activity Produced by Thermophilic Bacteria from a High-Altitude Hydrothermal System","volume":"15","author":"Pardo-Est\u00e9","year":"2024","journal-title":"Front Microbiol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/1040841X.2023.2197491","article-title":"Exploring Halophilic Environments as a Source of New Antibiotics","volume":"50","author":"Thompson","year":"2024","journal-title":"Crit Rev Microbiol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3390\/microbiolres15040169","article-title":"Disruption of Biofilm Formation by Dead Sea Soil Extracts: A Novel Approach Against Diabetic Foot Wound Isolates","volume":"15","author":"Zubair","year":"2024","journal-title":"Microbiol Res"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/v15041020","article-title":"Current Clinical Landscape and Global Potential of Bacteriophage Therapy","volume":"15","author":"Hitchcock","year":"2023","journal-title":"Viruses"},{"key":"B168","doi-asserted-by":"publisher","first-page":"128","DOI":"10.33696\/Signaling.4.100","article-title":"The Human Gut Phageome: Identification and Roles in the Diseases","volume":"4","author":"Nabi-Afjadi","year":"2023","journal-title":"J Cell Signal"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","article-title":"Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails to Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B170","doi-asserted-by":"publisher","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons Learned from the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B171","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00408-024-00700-7","article-title":"Phage Therapy for Respiratory Infections: Opportunities and Challenges","volume":"202","author":"Khosravi","year":"2024","journal-title":"Lung"},{"key":"B172","unstructured":"Bacteriophage Therapy for Patients with Difficult to Treat Bacterial Infections\n          \n          \n          2023"},{"key":"B173","article-title":"House of Commons, UK Parliament","volume-title":"The Antimicrobial Potential of Bacteriophages","year":"2024"},{"key":"B174","volume-title":"Policy Paper: Government's Response to the Science, Innovation and Technology Committee's Report 'The Antimicrobial Potential of Bacteriophages'","year":"2024"},{"key":"B175","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/v15030721","article-title":"The Future of Clinical Phage Therapy in the United Kingdom","volume":"15","author":"Jones","year":"2023","journal-title":"Viruses"},{"key":"B176","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/biomedicines9060584","article-title":"Natural Photosensitizers in Antimicrobial Photodynamic Therapy","volume":"9","author":"Polat","year":"2021","journal-title":"Biomedicines"},{"key":"B177","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.3390\/ijms23063209","article-title":"Applications of Antimicrobial Photodynamic Therapy Against Bacterial Biofilms","volume":"23","author":"Songca","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B178","doi-asserted-by":"publisher","first-page":"106307","DOI":"10.1016\/j.micpath.2023.106307","article-title":"Photodynamic Therapy for ESKAPE Pathogens: An Emerging Approach to Combat Antimicrobial Resistance (AMR)","volume":"183","author":"Mathur","year":"2023","journal-title":"Microb Pathog"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1039\/d0cs01051k","article-title":"The Role of the Light Source in Antimicrobial Photodynamic Therapy","volume":"52","author":"Piksa","year":"2023","journal-title":"Chem Soc Rev"},{"key":"B180","doi-asserted-by":"publisher","first-page":"103158","DOI":"10.1016\/j.pdpdt.2022.103158","article-title":"Clinical Acceptance of Antimicrobial Photodynamic Therapy in the Age of WHO Global Priority Pathogens: So what We Need to Move Forward?","volume":"40","author":"Sellera","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B181","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/photonics9050340","article-title":"Randomized and Controlled Clinical Studies on Antibacterial Photodynamic Therapy: An Overview","volume":"9","author":"Alves","year":"2022","journal-title":"Photonics"},{"key":"B182","doi-asserted-by":"publisher","first-page":"e2408759","DOI":"10.1002\/smll.202408759","article-title":"Deep Red-Light-Mediated Nitric Oxide and Photodynamic Synergistic Antibacterial Therapy for the Treatment of Drug-Resistant Bacterial Infections","volume":"21","author":"Lin","year":"2025","journal-title":"Small"},{"key":"B183","doi-asserted-by":"publisher","first-page":"113133","DOI":"10.1016\/j.jphotobiol.2025.113133","article-title":"Photodynamic Inactivation of KPC-Producing Klebsiella pneumoniae Difficult-to-Treat Resistance (DTR) by a Cationic Porphyrin","volume":"265","author":"de Freitas","year":"2025","journal-title":"J Photochem Photobiol B"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/antiox11091660","article-title":"Combined Antimicrobial Blue Light and Antibiotics as a Tool for Eradication of Multidrug-Resistant Isolates of Pseudomonas aeruginosa and Staphylococcus aureus: In Vitro and In Vivo Studies","volume":"11","author":"Wo\u017aniak","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B185","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s10103-025-04402-1","article-title":"The Effect of Photodynamic Therapy Using Gentamicin and Imipenem-Derived Carbon Dots on Pseudomonas aeruginosa Isolates","volume":"40","author":"Shiralizadeh","year":"2025","journal-title":"Lasers Med Sci"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pdpdt.2017.01.003","article-title":"Antimicrobial Activity of Photodynamic Therapy in Combination with Colistin Against a Pan-Drug Resistant Acinetobacter baumannii Isolated from Burn Patient","volume":"18","author":"Boluki","year":"2017","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B187","doi-asserted-by":"publisher","first-page":"e55926","DOI":"10.1371\/journal.pone.0055926","article-title":"Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus faecium in a Whole Animal Insect Model","volume":"8","author":"Chibebe Junior","year":"2013","journal-title":"PLoS One"},{"key":"B188","doi-asserted-by":"publisher","first-page":"117197","DOI":"10.1016\/j.ejmech.2024.117197","article-title":"Photosensitizer Associated with Efflux Pump Inhibitors as a Strategy for Photodynamic Therapy Against Bacterial Resistance","volume":"284","author":"da Cunha","year":"2025","journal-title":"Eur J Med Chem"},{"key":"B189","doi-asserted-by":"publisher","first-page":"104212","DOI":"10.1016\/j.pdpdt.2024.104212","article-title":"The Role of Efflux Pump Inhibitor in Enhancing Antimicrobial Efficiency of Ag NPs and MB as an Effective Photodynamic Therapy Agent","volume":"47","author":"Allamyradov","year":"2024","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B190","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/photob.2023.0194","article-title":"Efflux Pump Inhibitor Potentiates the Antimicrobial Photodynamic Inactivation of Multidrug-Resistant Acinetobacter baumannii","volume":"42","author":"Shirdel","year":"2024","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s43630-025-00735-6","article-title":"Exploring Catalase Inhibition as an Adjuvant to Antimicrobial Photodynamic Therapy Against Staphylococcus aureus","volume":"24","author":"Surur","year":"2025","journal-title":"Photochem Photobiol Sci"},{"key":"B192","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jds.2023.11.006","article-title":"Application of Antimicrobial Sonodynamic Therapy as a Potential Treatment Modality in Dentistry: A Literature Review","volume":"19","author":"Pourhajibagher","year":"2024","journal-title":"J Dent Sci"},{"key":"B193","doi-asserted-by":"publisher","first-page":"105591","DOI":"10.1016\/j.ultsonch.2021.105591","article-title":"Sonodynamic Antimicrobial Chemotherapy: An Emerging Alternative Strategy for Microbial Inactivation","volume":"75","author":"Fan","year":"2021","journal-title":"Ultrason Sonochem"},{"key":"B194","doi-asserted-by":"publisher","first-page":"dlaf045","DOI":"10.1093\/jacamr\/dlaf045","article-title":"Enhancing Biofilm Disruption and Bactericidal Efficiency Using Vancomycin-Loaded Microbubbles in Sonodynamic Therapy","volume":"7","author":"Mu","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"B195","doi-asserted-by":"publisher","first-page":"e2501131","DOI":"10.1002\/smll.202501131","article-title":"A Facile Coordination Polymer Nanoparticle for Sonodynamic Therapy Combating Drug-Resistant Bacteria","volume":"30","author":"Song","year":"2025","journal-title":"Small"},{"key":"B196","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.niox.2025.01.001","article-title":"The Antimicrobial Effects of Nitric Oxide: A Narrative Review","volume":"155","author":"Okda","year":"2025","journal-title":"Nitric Oxide"},{"key":"B197","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/ETLS20230114","article-title":"The Nitric Oxide Paradox: Antimicrobial and Inhibitor of Antibiotic Efficacy","volume":"8","author":"Webster","year":"2024","journal-title":"Emerg Top Life Sc"},{"key":"B198","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s15010-016-0879-x","article-title":"Gaseous Nitric Oxide to Treat Antibiotic Resistant Bacterial and Fungal Lung Infections in Patients with Cystic Fibrosis: A Phase I Clinical Study","volume":"44","author":"Deppisch","year":"2016","journal-title":"Infection"},{"key":"B199","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.ymthe.2017.06.021","article-title":"Low-Dose Nitric Oxide as Targeted Anti-Biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis","volume":"25","author":"Howlin","year":"2017","journal-title":"Mol Ther"},{"key":"B200","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jcf.2019.05.002","article-title":"Pilot Study to Test Inhaled Nitric Oxide in Cystic Fibrosis Patients with Refractory Mycobacterium abscessus Lung Infection","volume":"19","author":"Bentur","year":"2020","journal-title":"J Cyst Fibros"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1536714","DOI":"10.1155\/2020\/1536714","article-title":"High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting Burkholderia multivorans","volume":"2020","author":"Bartley","year":"2020","journal-title":"Case Rep Pediatr"},{"key":"B202","doi-asserted-by":"publisher","first-page":"107069","DOI":"10.1016\/j.rmed.2022.107069","article-title":"Inhaled Nitric Oxide for Adults with Pulmonary NonTuberculous Mycobacterial Infection","volume":"206","author":"Flume","year":"2023","journal-title":"Respir Med"},{"key":"B203","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijmy.ijmy_153_18","article-title":"Antimycobacterial Strategies to Evade Antimicrobial Resistance in the Nontuberculous Mycobacteria","volume":"8","author":"Millar","year":"2019","journal-title":"Int J Mycobacteriol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/antibiotics13111047","article-title":"Nanoparticle-Based Nitric Oxide Donors: Exploring Their Antimicrobial and Anti-Biofilm Capabilities","volume":"13","author":"Tortella","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B205","unstructured":"Rebyota\n          \n          \n          2022"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40265-022-01797-x","article-title":"Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection","volume":"82","author":"Khanna","year":"2022","journal-title":"Drugs"},{"key":"B207","unstructured":"FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection\n          \n          \n          2023"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/apt.15526","article-title":"Faecal Microbiota Transplant Decreases Mortality in Severe and Fulminant Clostridioides difficile Infection in Critically Ill Patients","volume":"50","author":"Tixier","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B209","doi-asserted-by":"publisher","first-page":"2478317","DOI":"10.1080\/07853890.2025.2478317","article-title":"Exploring the Role of Gut Microbiota in Antibiotic Resistance and Prevention","volume":"57","author":"Dongre","year":"2025","journal-title":"Ann Med"},{"key":"B210","doi-asserted-by":"publisher","first-page":"e058124","DOI":"10.1136\/bmjopen-2021-058124","article-title":"Randomised, Double-Blind, Placebo-Controlled, Phase 2, Superiority Trial to Demonstrate the Effectiveness of Faecal Microbiota Transplantation for Selective Intestinal Decolonisation of Patients Colonised by Carbapenemase-Producing Klebsiella pneumoniae (KAPEDIS)","volume":"12","author":"P\u00e9rez-Nadales","year":"2022","journal-title":"BMJ Open"},{"key":"B211","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cmi.2019.04.006","article-title":"Faecal Microbiota Transplantation for Eradicating Carriage of Multidrug-Resistant Organisms: A Systematic Review","volume":"25","author":"Saha","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B212","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hep4.1639","article-title":"Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials","volume":"5","author":"Bajaj","year":"2020","journal-title":"Hepatol Commun"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/cid\/ciaa948","article-title":"Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized with Multidrug-Resistant Organisms","volume":"72","author":"Ghani","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B214","doi-asserted-by":"publisher","first-page":"eabo2750","DOI":"10.1126\/scitranslmed.abo2750","article-title":"Fecal Microbiota Transplantation Promotes Reduction of Antimicrobial Resistance by Strain Replacement","volume":"15","author":"Woodworth","year":"2023","journal-title":"Sci Transl Med"},{"key":"B215","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00005-016-0387-9","article-title":"Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host","volume":"64","author":"Bili\u0144ski","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B216","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40001-021-00508-8","article-title":"Tandem Fecal Microbiota Transplantation Cycles in an Allogeneic Hematopoietic Stem Cell Transplant Recipient Targeting Carbapenem-Resistant Enterobacteriaceae Colonization: A Case Report and Literature Review","volume":"26","author":"Su","year":"2021","journal-title":"Eur J Med Res"},{"key":"B217","doi-asserted-by":"publisher","first-page":"684659","DOI":"10.3389\/fcimb.2021.684659","article-title":"Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized with Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation","volume":"11","author":"Innes","year":"2021","journal-title":"Front Cell Infect Microbio"},{"key":"B218","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13073-024-01306-7","article-title":"Long-Term Beneficial Effect of Faecal Microbiota Transplantation on Colonisation of Multidrug-Resistant Bacteria and Resistome Abundance in Patients with Recurrent Clostridioides difficile Infection","volume":"16","author":"Nooij","year":"2024","journal-title":"Genome Med"},{"key":"B219","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000502336","article-title":"Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections","volume":"9","author":"Grosen","year":"2019","journal-title":"Case Rep Nephrol Dial"},{"key":"B220","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/07853890.2021","article-title":"Is There a Role of Faecal Microbiota Transplantation in Reducing Antibiotic Resistance Burden in Gut? A Systematic Review and Meta-Analysis","volume":"53","author":"Dharmaratne","year":"2021","journal-title":"Ann Med"},{"key":"B221","unstructured":"Safety Alert: Fecal Microbiota for Transplantation and Risk of Transmission of Multi-Drug Resistant Organisms\n          \n          \n          2019"},{"key":"B222","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1053\/j.gastro.2020.08.039","article-title":"Monitoring Fecal Microbiota Transplantation Practice in a Rapidly Evolving Health and Regulatory Environment","volume":"159","author":"Kelly","year":"2020","journal-title":"Gastroenterology"},{"key":"B223","doi-asserted-by":"publisher","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal Microbiota Transplantation: Current Challenges and Future Landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"B224","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.medmic.2020.100027","article-title":"Fecal Microbiota Transplantation: Uses, Questions, and Ethics","volume":"6","author":"Grigoryan","year":"2020","journal-title":"Med Microecol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/1073110519897730","article-title":"The Ethics of Fecal Microbiota Transplant as a Tool for Antimicrobial Stewardship Programs","volume":"47","author":"Murray","year":"2019","journal-title":"J L Med Ethics"},{"key":"B226","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MOG.0000000000000792","article-title":"Faecal Microbiota Replacement to Eradicate Antimicrobial Resistant Bacteria in the Intestinal Tract - a Systematic Review","volume":"38","author":"Bilsen","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"B227","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jinf.2022.04.028","article-title":"Fecal Microbiota Transplantation for Carbapenem-Resistant Enterobacteriaceae: A Systematic Review","volume":"84","author":"Macare\u00f1o-Castro","year":"2022","journal-title":"J Infect"},{"key":"B228","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1099\/mic.0.001025","article-title":"Predatory Bacteria as Living Antibiotics - where Are We Now?","volume":"167","author":"Atterbury","year":"2021","journal-title":"Microbiology (Reading)"},{"key":"B229","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1080\/1040841X.2021.1908956","article-title":"Bdellovibrio Bacteriovorus: A Potential 'Living Antibiotic' to Control Bacterial Pathogens","volume":"47","author":"Cavallo","year":"2021","journal-title":"Crit Rev Microbiol"},{"key":"B230","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-97-7320-6_11","article-title":"Bacteriocin and Predatory Bacteria","volume-title":"Antimicrobial Resistance in Aquaculture and Aquatic Environments","author":"Mahboub","year":"2025"},{"key":"B231","doi-asserted-by":"publisher","first-page":"045","DOI":"10.23910\/1.2023.3168","article-title":"Predatory Bacteria: A Novel Approach to Antibiotic Substitution","volume":"14","author":"George","year":"2023","journal-title":"Int J Bio-Resource Stress Management"},{"key":"B232","doi-asserted-by":"publisher","first-page":"e0309422","DOI":"10.1128\/spectrum.03094-22","article-title":"Outer Membrane Porin F in E. coli Is Critical for Effective Predation by Bdellovibrio","volume":"10","author":"Mun","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B233","doi-asserted-by":"publisher","first-page":"001433","DOI":"10.1099\/mic.0.001433","article-title":"Predatory Bacteria Prevent the Proliferation of Intraocular Serratia marcescens and Fluoroquinolone-Resistant Pseudomonas aeruginosa","volume":"170","author":"Romanowski","year":"2024","journal-title":"Microbiology (Reading)"},{"key":"B234","doi-asserted-by":"publisher","first-page":"10523","DOI":"10.1038\/s41598-022-14378-5","article-title":"Strain-Specific Predation of Bdellovibrio bacteriovorus on Pseudomonas aeruginosa with a Higher Range for Cystic Fibrosis than for Bacteremia Isolates","volume":"12","author":"Saralegui","year":"2022","journal-title":"Sci Rep"},{"key":"B235","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tim.2021.05.005","article-title":"Towards Efficient Immunotherapy for Bacterial Infection","volume":"30","author":"McCulloch","year":"2022","journal-title":"Trends Microbiol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1021\/acsinfecdis.5c00001","article-title":"Recent Advances in Immunotherapeutic and Vaccine-Based Approaches for the Treatment of Drug-Resistant Bacterial Infections","volume":"11","author":"Odoom","year":"2025","journal-title":"ACS Infect Dis"},{"key":"B237","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The Role of Bacterial Vaccines in the Fight Against Antimicrobial Resistance: An Analysis of the Preclinical and Clinical Development Pipeline","volume":"4","author":"Frost","year":"2023","journal-title":"Lancet Microbe"},{"key":"B238","unstructured":"Estimating the Impact of Vaccines in Reducing Antimicrobial Resistance and Antibiotic Use: Technical Report\n          \n          \n          2024"},{"key":"B239","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s44259-024-00068-x","article-title":"Challenges and Applications of Artificial Intelligence in Infectious Diseases and Antimicrobial Resistance","volume":"3","author":"Cesaro","year":"2025","journal-title":"NPJ Antimicrob Resist"},{"key":"B240","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A Deep Learning Approach to Antibiotic Discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"B241","doi-asserted-by":"publisher","first-page":"e1010613","DOI":"10.1371\/journal.pcbi.1010613","article-title":"A Machine Learning Model Trained on a High-Throughput Antibacterial Screen Increases the Hit Rate of Drug Discovery","volume":"18","author":"Rahman","year":"2022","journal-title":"Plos Comput Biol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/antibiotics13100971","article-title":"Identifying Potential Natural Antibiotics from Unani Formulas Through Machine Learning Approaches","volume":"13","author":"Nasution","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B243","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1021\/acs.molpharmaceut.8b00083","article-title":"Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery","volume":"15","author":"Lane","year":"2018","journal-title":"Mol Pharm"},{"key":"B244","doi-asserted-by":"publisher","first-page":"102168","DOI":"10.1016\/j.tube.2022.102168","article-title":"Mycobacterium abscessus Drug Discovery Using Machine Learning","volume":"132","author":"Schmalstig","year":"2022","journal-title":"Tuberculosis (Edinb)"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1482186","DOI":"10.3389\/fcimb.2024.1482186","article-title":"Artificial Intelligence in Predicting Pathogenic Microorganisms' Antimicrobial Resistance: Challenges, Progress, and Prospects","volume":"14","author":"Li","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s44259-025-00085-4","article-title":"How AI Can Help Us Beat AMR","volume":"3","author":"Arnold","year":"2025","journal-title":"NPJ Antimicrob Resist"},{"key":"B247","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40779-024-00510-1","article-title":"Antimicrobial Resistance Crisis: Could Artificial Intelligence Be the Solution?","volume":"11","author":"Liu","year":"2024","journal-title":"Mil Med Res"},{"key":"B248","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.csbj.2025.01.006","article-title":"The Role of Artificial Intelligence and Machine Learning in Predicting and Combating Antimicrobial Resistance","volume":"27","author":"Bilal","year":"2025","journal-title":"Comput Struct Biotechnol J"},{"key":"B249","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13205-025-04282-w","article-title":"Artificial Intelligence in Drug Resistance Management","volume":"15","author":"Elalouf","year":"2025","journal-title":"3 Biotech"},{"key":"B250","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1017\/ash.2025.47","article-title":"Can We Rely on Artificial Intelligence to Guide Antimicrobial Therapy? A Systematic Literature Review","volume":"5","author":"AlGain","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"1258159","DOI":"10.3389\/fbrio.2023.1258159","article-title":"Artificial Intelligence in Accelerating Vaccine Development - Current and Future Perspectives","volume":"2","author":"Kaushik","year":"2023","journal-title":"Front Bacteriol"},{"key":"B252","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3389\/fimmu.2019.00751","article-title":"The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front Immunol"},{"key":"B253","unstructured":"Oxford Launches Major New AI Vaccine Research Programme with the Ellison Institute of Technology"},{"key":"B254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/cjms.2020.1426","article-title":"Microfluidic Organ-Chips and Infectious Diseases: Insights from the Development and Applications Perspective","volume":"7","author":"Baddal","year":"2022","journal-title":"Cyprus J Med Sci"},{"key":"B255","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.apsb.2023.02.006","article-title":"Emerging Trends in Organ-on-a-Chip Systems for Drug Screening","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B256","doi-asserted-by":"publisher","first-page":"1139229","DOI":"10.3389\/fphar.2023.1139229","article-title":"Revolutionizing Drug Development: Harnessing the Potential of Organ-On-Chip Technology for Disease Modeling and Drug Discovery","volume":"14","author":"Sunildutt","year":"2023","journal-title":"Front Pharmacol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","article-title":"A Guide to the Organ-On-a-Chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"B258","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1039\/c5lc00392j","article-title":"A Four-Organ-Chip for Interconnected Long-Term Co-Culture of Human Intestine, Liver, Skin and Kidney Equivalents","volume":"15","author":"Maschmeyer","year":"2015","journal-title":"Lab Chip"},{"key":"B259","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/toxins13110775","article-title":"Gut-Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing Escherichia coli","volume":"13","author":"Lee","year":"2021","journal-title":"Toxins (Basel)"},{"key":"B260","doi-asserted-by":"publisher","first-page":"e0021924","DOI":"10.1128\/aac.00219-24","article-title":"Evaluating Nephrotoxicity Reduction in a Novel Polymyxin B Formulation: Insights from a 3D Kidney-on-a-Chip Model","volume":"68","author":"Payasi","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"B261","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1126\/science.adg6276","article-title":"FDA No Longer Has to Require Animal Testing for New Drugs","volume":"379","author":"Wadman","year":"2023","journal-title":"Science"},{"key":"B262","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1039\/d1lc00241d","article-title":"Standardisation Needs for Organ on Chip Devices","volume":"21","author":"Piergiovanni","year":"2021","journal-title":"Lab Chip"},{"key":"B263","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biotno.2024.01.001","article-title":"Organ-On-Chip Technology: Opportunities and Challenges","volume":"5","author":"Srivastava","year":"2024","journal-title":"Biotechnol Notes"},{"key":"B264","volume-title":"Organ on Chip: Building a Roadmap Towards Standardisation","author":"Piergiovanni","year":"2021"},{"key":"B265","unstructured":"Organ-on-a-Chip Technologies Network\n          \n          \n          2025"},{"key":"B266","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1039\/d4lc00489b","article-title":"A 3D-Printed Multi-Compartment Organ-On-Chip Platform with a Tubing-Free Pump Models Communication with the Lymph Node","volume":"25","author":"Cook","year":"2025","journal-title":"Lab Chip"},{"key":"B267","unstructured":"Case Study: VDEC Pre-Clinical Team Helps to Develop Organ-On-a-Chip to Protect Human Health\n          \n          \n          2025"},{"key":"B268","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/pharmaceutics16050666","article-title":"Lymph Node-On-Chip Technology: Cutting-Edge Advances in Immune Microenvironment Simulation","volume":"16","author":"Wang","year":"2024","journal-title":"Pharmaceutics"},{"key":"B269","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human Organs-On-Chips for Disease Modelling, Drug Development and Personalized Medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat Rev Gene"},{"key":"B270","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3390\/medicina59101719","article-title":"Applications of Lab on a Chip in Antimicrobial Susceptibility of Staphylococcus Aureus: A Systematic Review","volume":"59","author":"Ardila","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"B271","unstructured":"Confronting Antimicrobial Resistance 2024 to 2029\n          \n          2024"},{"key":"B272","unstructured":"Council Recommendation on Stepping up EU Actions to Combat Antimicrobial Resistance in a One Health approach\n          \n          2023"}],"container-title":["British Journal of Biomedical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2026.15559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:04:21Z","timestamp":1771995861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2026.15559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":272,"alternative-id":["10.3389\/bjbs.2026.15559"],"URL":"https:\/\/doi.org\/10.3389\/bjbs.2026.15559","relation":{},"ISSN":["2474-0896"],"issn-type":[{"value":"2474-0896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"article-number":"15559"}}